Package 0002-7026-60

{"route": ["ORAL"], "spl_id": "d1386cab-a58a-496f-af23-470b59b7831e", "openfda": {"nui": ["N0000175605", "N0000193934", "N0000185503", "N0000187062", "N0000182140", "N0000190114", "N0000190113"], "unii": ["JNA39I7ZVB"], "rxcui": ["2629343", "2629349", "2629351", "2629353"], "spl_set_id": ["bd551845-0878-49a4-860f-839b83f6b801"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Bruton's Tyrosine Kinase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, COATED in 1 BOTTLE (0002-7026-60)", "package_ndc": "0002-7026-60", "marketing_start_date": "20230127"}, {"sample": true, "description": "30 TABLET, COATED in 1 BOTTLE (0002-7026-99)", "package_ndc": "0002-7026-99", "marketing_start_date": "20230215"}], "brand_name": "JAYPIRCA", "product_id": "0002-7026_d1386cab-a58a-496f-af23-470b59b7831e", "dosage_form": "TABLET, COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Bruton's Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0002-7026", "generic_name": "pirtobrutinib", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "JAYPIRCA", "active_ingredients": [{"name": "PIRTOBRUTINIB", "strength": "100 mg/1"}], "application_number": "NDA216059", "marketing_category": "NDA", "marketing_start_date": "20230127", "listing_expiration_date": "20261231"}